Intercept Pharma
-
Ticker
ICPT
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in New York City, New York
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia.
Intercept Pharma
Most Recent Annual Report
MOST RECENT
2020 Annual Report and Form 10K
Older/Archived Annual Reports